{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:48:47Z","timestamp":1764841727737},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jhep.2013.07.032","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T04:30:23Z","timestamp":1375763423000},"page":"1223-1230","source":"Crossref","is-referenced-by-count":20,"title":["Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors"],"prefix":"10.1016","volume":"59","author":[{"given":"Louise","family":"Barbier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Cros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Borentain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Botta-Fridlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves-Patrice","family":"Le Treut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Hardwigsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.07.032_b0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/172603a0","article-title":"Actively acquired tolerance of foreign cells","volume":"172","author":"Billingham","year":"1953","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.07.032_b0010","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0140-6736(05)77739-4","article-title":"Prope tolerance, perioperative campath H1, and low-dose cyclosporin monotherapy in renal allograft recipients","volume":"351","author":"Calne","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.07.032_b0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trim.2004.05.008","article-title":"Prope tolerance-the future of organ transplantation from the laboratory to the clinic","volume":"13","author":"Calne","year":"2004","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jhep.2013.07.032_b0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.trim.2004.05.002","article-title":"The concept of \u00abpartial\u00bb clinical tolerance","volume":"13","author":"Cortesini","year":"2004","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jhep.2013.07.032_b0025","first-page":"648","article-title":"Terminology for hepatic allograft rejection","volume":"22","author":"International working party","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.032_b0030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document","volume":"25","author":"An international panel","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.032_b0035","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/00007890-200109270-00020","article-title":"Risk factors for chronic rejection after pediatric liver transplantation","volume":"72","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.07.032_b0040","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3748\/wjg.v10.i13.1857","article-title":"Cytomegalovirus and chronic allograft rejection in liver transplantation","volume":"10","author":"Gao","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.07.032_b0045","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.032_b0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/jhep.2002.31726","article-title":"Histologic and biochemical changes during the evolution of chronic rejection of liver allografts","volume":"35","author":"Neil","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.032_b0055","first-page":"379","article-title":"Causes of mortality in 344 adult liver transplant (OLT) recipients who survived for more than 10years","volume":"3","author":"Chinnakotla","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.07.032_b0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5414\/CNP75150","article-title":"Chronic kidney disease after orthotopic liver transplantation in patients receiving tacrolimus","volume":"75","author":"Garces","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jhep.2013.07.032_b0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199807150-00010","article-title":"Chronic renal failure following liver transplantation: a retrospective analysis","volume":"66","author":"Fischer","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.07.032_b0070","doi-asserted-by":"crossref","first-page":"e24387","DOI":"10.1371\/journal.pone.0024387","article-title":"Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis","volume":"6","author":"Kong","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.07.032_b0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/SLA.0b013e3181896278","article-title":"Liver transplantation for HCC under calcineurin inhibitors: reassessment of risk factors for tumor recurrence","volume":"248","author":"Vivarelli","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2013.07.032_b0080","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/lt.20903","article-title":"Mycophenolate Mofetil in combination with reduction of Calcineurin Inhibitors for chronic renal dysfunction after liver transplantation","volume":"12","author":"Pageaux","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0085","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"AASLD. Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.032_b0090","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/lt.21404","article-title":"The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers","volume":"14","author":"Krasinkas","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm in the grading of activity in chronic hepatitis C. The METAVIR cooperative study group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.032_b0100","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/ndt\/17.11.1909","article-title":"Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients@: validity of a new (MDRD) prediction equation","volume":"17","author":"Vervoort","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2013.07.032_b0105","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0041-1345(96)00535-0","article-title":"Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up","volume":"29","author":"Mazariegos","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.07.032_b0110","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.transproceed.2005.03.070","article-title":"Long-term outcome of immunosuppression withdrawal after liver transplantation","volume":"37","author":"Girlanda","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.07.032_b0115","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2005.11.047","article-title":"Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence","volume":"44","author":"Tisone","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.07.032_b0120","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","article-title":"Tolerogenic immunosuppression for organ transplantation","volume":"361","author":"Starzl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.07.032_b0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/01.TP.0000162084.46555.10","article-title":"Tolerance: is it worth the risk?","volume":"79","author":"Eason","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.07.032_b0130","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1600-6143.2004.00743.x","article-title":"The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation","volume":"5","author":"Tryphonopoulos","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.07.032_b0135","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2009.03.006","article-title":"Operational tolerance after liver transplantation","volume":"50","author":"Orlando","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.07.032_b0140","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/lt.23481","article-title":"Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance","volume":"18","author":"Banff working group on liver allograft pathology","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.TP.0000142674.78268.01","article-title":"Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus","volume":"78","author":"Marcos","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.07.032_b0150","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/01.TP.0000116562.15920.43","article-title":"Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation","volume":"77","author":"Tzakis","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.07.032_b0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TP.0000164349.54297.95","article-title":"Preliminary results of a \u00abprope\u00bb tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation","volume":"80","author":"De Ruvo","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.07.032_b0160","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/lt.21185","article-title":"Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation","volume":"13","author":"Soliman","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/lt.21309","article-title":"Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors","volume":"14","author":"Bajjoka","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/lt.20144","article-title":"Interleukin-2 receptor antibpdy (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage","volume":"10","author":"Liu","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0175","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/lt.22292","article-title":"Conversion to everolimus in maintenance liver transplant patients: a multicenter retrospective analysis","volume":"17","author":"Saliba","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0180","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/00007890-200005150-00025","article-title":"Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil","volume":"69","author":"Barkmann","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.07.032_b0185","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1600-6143.2012.04049.x","article-title":"A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation\u2013PROTECT","volume":"12","author":"Fischer","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.07.032_b0190","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial","volume":"12","author":"De Simone","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.07.032_b0195","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1600-6143.2011.03486.x","article-title":"Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study","volume":"11","author":"Boudjema","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.07.032_b0200","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/TP.0b013e318176b1fd","article-title":"Protocol liver allograft biopsies","volume":"85","author":"Mells","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.07.032_b0205","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/jhep.2003.50231","article-title":"All liver recipients benefit from the protocol 10-year liver biopsies","volume":"37","author":"Sebagh","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.032_b0210","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/PAS.0b013e3181622490","article-title":"Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests","volume":"32","author":"Abraham","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2013.07.032_b0215","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/lt.21781","article-title":"Late protocol liver biopsies in the liver allograft: a neglected investigation?","volume":"15","author":"Mells","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0220","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2011.11.016","article-title":"Twenty-year protocol liver biopsies: invasive but iseful for the management of liver recipients","volume":"56","author":"Sebagh","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.07.032_b0225","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/PAS.0b013e31817a8e96","article-title":"Significance of central perivenulitis in pediatric liver transplantation","volume":"32","author":"Abraham","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2013.07.032_b0230","first-page":"S84","article-title":"Klint- Malm G, et al. Lessons learned from the ITN030ST immunosuppression withdrawal (ISW) trial in liver transplant recipients [abstract]","volume":"17","author":"Shaked","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.07.032_b0235","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1002\/lt.22377","article-title":"The failure of immunosuppression withdrawal: Patient benefit is not detectable, inducible, or reproducible","volume":"17","author":"Porrett","year":"2011","journal-title":"Liver Transpl"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813005473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813005473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T00:22:41Z","timestamp":1539476561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813005473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0168827813005473"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.07.032","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}